Foghorn Therapeutics Inc. (FHTX): Insider Trading, Congress Trades & Research | Tormere

FHTX

$1.87-1.84%visit website

Foghorn Therapeutics Inc.

Market Cap

$111M

Live price × SEC shares (Jul 31, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

3.14

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

3.0

TTM to Jun 2026 · revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	8,153	9,247	3,267	16,072	36,739
Research & development	20,002	22,046	18,259	18,523	78,830
Total operating expenses	26,654	33,125	24,840	24,877	109,496
Operating income	(18,501)	(23,878)	(21,573)	(8,805)	(72,757)
Net income	(15,849)	(21,664)	(19,875)	(7,191)	(64,579)
EPS (basic) ($)	(0.25)		(0.29)	(0.10)	(0.99)
EPS (diluted) ($)	(0.25)		(0.29)	(0.10)	(0.99)
Weighted avg. shares (basic)	63,029		69,540	70,629
Weighted avg. shares (diluted)	63,029		69,540	70,629

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 6, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 24 more quarters, back to Sep 2019, with Tormere Pro.

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

No Form 4 transactions on record.

Recent News

Foghorn Therapeutics Inc. (FHTX) Stock Price, News, Quote & History

Yahoo! Finance Canada · 2026-11-03

Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November

Yahoo · 2026-11-03

Two fireside chats and a presentation are scheduled for Foghorn CEO Adrian Gottschalk in November.

Stock Titan · 2026-11-03

Iovance Biotherapeutics (IOVA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Yahoo · 2026-10-29

Foghorn Therapeutics Inc. (FHTX) Expected to Beat Earnings Estimates: Should You Buy?

Yahoo · 2026-10-28

Could You Have Seen The Run In Kymera Stock Coming?

Yahoo · 2026-10-26

Foghorn Therapeutics (FHTX) Stock Fair Value Moves Lower After Pipeline And Lilly Reset

Yahoo · 2026-10-22

FHTX Stock Extends Sell-Off After Lilly Collaboration Ends — Wedbush Slashes Target By 80%

Stocktwits · 2026-10-02

Why is Foghorn Therapeutics stock plunging today?

Investing.com · 2026-10-02

Sector Update: Healthcare Stocks Fall Late Afternoon

Yahoo Finance · 2026-10-01

Foghorn Stock Sinks as Lilly Scraps Cancer Deal, Forcing 40% Layoffs

Yahoo Finance · 2026-10-01

Top Midday Decliners

Yahoo Finance · 2026-10-01

Lilly, Foghorn part ways; Wave’s FDA-approved plans

Yahoo Finance · 2026-10-01

FHTX Stock On Track For Record Low — Why Did Foghorn And Lilly Pull The Plug On Cancer Drug?

TradingView · 2026-10-01

Foghorn stock down as Lilly exits collaboration (FHTX:NASDAQ)

Seeking Alpha · 2026-10-01

Informational purposes only, not investment advice.